Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 99-32-1 | MDL No. : | MFCD00006577 |
Formula : | C7H4O6 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PBAYDYUZOSNJGU-UHFFFAOYSA-N |
M.W : | 184.10 | Pubchem ID : | 7431 |
Synonyms : |
NSC 3979
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 38.9 |
TPSA : | 104.81 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.71 cm/s |
Log Po/w (iLOGP) : | -0.01 |
Log Po/w (XLOGP3) : | -0.4 |
Log Po/w (WLOGP) : | 0.04 |
Log Po/w (MLOGP) : | -1.25 |
Log Po/w (SILICOS-IT) : | 0.17 |
Consensus Log Po/w : | -0.29 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -0.94 |
Solubility : | 21.2 mg/ml ; 0.115 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.34 |
Solubility : | 8.47 mg/ml ; 0.046 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.68 |
Solubility : | 38.1 mg/ml ; 0.207 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.57 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
46% | Stage #1: With sodium ethanolate In ethanol at 60℃; for 15 h; Stage #2: With hydrogenchloride; water In ethanol for 44 h; |
Chelidonic acid was synthesized using an adapted literature protocol.33 In a typical experiment, EtONa (69.4 g, 1.02 mol) was suspended in ethanol (300 mL). After 45 min at 60°C, a solution of dry acetone (29 g, 38 mL, 0.5 mol) and diethyl oxalate (155 g, 144 mL, 1.06 mol) was added over a period of 1 h. After the addition was complete, the solution was maintained at 60°C and stirred for an additional 14 h. Then, 230 mL of HCl (37percent aqueous solution) and 100 mL of water were added and the mixture was stirred for 1 day. After 24 h, about half of aqueous ethanol was removed under reduced pressure then 300 mL of water and 60mL of HCl (37percent aqueous solution) were added to this mixture and stirring was continued for 20 h at 50°C. The resulting solid was filtered off, washed first with water then with acetone before recrystallization from boiling water using charcoal. The filtrate was left at room temperature until formation of crystals. The white crystals were collected and dried under vacuum to give the desired compound 12 (42.3 g, 46percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With ammonia In water at 20℃; for 48 h; | Chelidamic acid was synthesized using an adapted literature protocol.33 In a typical experiment, 425 mL of NH3 (30percent aqueous solution) was added dropwise at 0°C to 12 (41.8 g, 0.21 mol) over a period of 1 h. After the addition was complete, the resulting suspension was stirred at room temperature for 48 h. The excess of aqueous ammonia solution was removed under reduced pressure and the residue was refluxed for 15 min with 50 mL of water using charcoal. After filtration, the hot filtrate was collected and after return to room temperature acidified with HCl (37percent aqueous solution) until pH=1. The resulting white solid was filtered off, washed several times with cold water and dried under vacuum for 16 h. The desired compound 13 was obtained as a white solid (42 g, 98percent). |
[ 1551-45-7 ]
Ethyl 4-oxo-4H-pyran-2-carboxylate
Similarity: 0.91
[ 1219-33-6 ]
5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
Similarity: 0.74
[ 119736-16-2 ]
3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
Similarity: 0.72
[ 15771-06-9 ]
5-(Benzyloxy)-2-(hydroxymethyl)-4H-pyran-4-one
Similarity: 0.67
[ 79725-98-7 ]
Pentadecyl 4-oxo-6-((palmitoyloxy)methyl)-4H-pyran-3-carboxylate
Similarity: 0.66
[ 31518-14-6 ]
3,4-Dihydro-2H-pyran-6-carboxylic acid
Similarity: 0.80
[ 1219-33-6 ]
5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
Similarity: 0.74
[ 56172-36-2 ]
5-Hydroxybenzofuran-2-carboxylic acid
Similarity: 0.73
[ 119736-16-2 ]
3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
Similarity: 0.72
[ 1551-45-7 ]
Ethyl 4-oxo-4H-pyran-2-carboxylate
Similarity: 0.91
[ 31518-14-6 ]
3,4-Dihydro-2H-pyran-6-carboxylic acid
Similarity: 0.80
[ 1219-33-6 ]
5-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
Similarity: 0.74
[ 119736-16-2 ]
3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid
Similarity: 0.72
[ 15771-06-9 ]
5-(Benzyloxy)-2-(hydroxymethyl)-4H-pyran-4-one
Similarity: 0.67